LINDSEY ROBERSON: Open Payments
NPI 1235711250 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 69 payments from 16 companies in 2025. Trend: 2023 $1,220 · 2024 $956 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $207 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $198 |
| Novo Nordisk Inc | 13 | $190 |
| GlaxoSmithKline, LLC. | 7 | $120 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Lilly USA, LLC | 3 | $48 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
Products named: Kerendia, TRELEGY ELLIPTA, OTEZLA, EVENITY, REXULTI, Wegovy, VOQUEZNA, Ozempic.
Industry payments across NC — which companies pay providers there.
